Kaposi's Sarcoma Herpesvirus microRNAs Target Caspase 3 and Regulate Apoptosis
Kaposi's sarcoma herpesvirus (KSHV) encodes a cluster of twelve micro (mi)RNAs, which are abundantly expressed during both latent and lytic infection. Previous studies reported that KSHV is able to inhibit apoptosis during latent infection; we thus tested the involvement of viral miRNAs in this process. We found that both HEK293 epithelial cells and DG75 cells stably expressing KSHV miRNAs were protected from apoptosis. Potential cellular targets that were significantly down-regulated upon KSHV miRNAs expression were identified by microarray profiling. Among them, we validated by luciferase reporter assays, quantitative PCR and western blotting caspase 3 (Casp3), a critical factor for the control of apoptosis. Using site-directed mutagenesis, we found that three KSHV miRNAs, miR-K12-1, 3 and 4-3p, were responsible for the targeting of Casp3. Specific inhibition of these miRNAs in KSHV-infected cells resulted in increased expression levels of endogenous Casp3 and enhanced apoptosis. Altogether, our results suggest that KSHV miRNAs directly participate in the previously reported inhibition of apoptosis by the virus, and are thus likely to play a role in KSHV-induced oncogenesis.
Vyšlo v časopise:
Kaposi's Sarcoma Herpesvirus microRNAs Target Caspase 3 and Regulate Apoptosis. PLoS Pathog 7(12): e32767. doi:10.1371/journal.ppat.1002405
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002405
Souhrn
Kaposi's sarcoma herpesvirus (KSHV) encodes a cluster of twelve micro (mi)RNAs, which are abundantly expressed during both latent and lytic infection. Previous studies reported that KSHV is able to inhibit apoptosis during latent infection; we thus tested the involvement of viral miRNAs in this process. We found that both HEK293 epithelial cells and DG75 cells stably expressing KSHV miRNAs were protected from apoptosis. Potential cellular targets that were significantly down-regulated upon KSHV miRNAs expression were identified by microarray profiling. Among them, we validated by luciferase reporter assays, quantitative PCR and western blotting caspase 3 (Casp3), a critical factor for the control of apoptosis. Using site-directed mutagenesis, we found that three KSHV miRNAs, miR-K12-1, 3 and 4-3p, were responsible for the targeting of Casp3. Specific inhibition of these miRNAs in KSHV-infected cells resulted in increased expression levels of endogenous Casp3 and enhanced apoptosis. Altogether, our results suggest that KSHV miRNAs directly participate in the previously reported inhibition of apoptosis by the virus, and are thus likely to play a role in KSHV-induced oncogenesis.
Zdroje
1. HanahanDWeinbergRA 2000 The hallmarks of cancer. Cell 100 57 70
2. HanahanDWeinbergRA 2011 Hallmarks of cancer: the next generation. Cell 144 646 674
3. GanemD 2007 Kaposi's sarcoma-associated herpesvirus. KnipeDMHowleyPMGriffinDELambRAMartinMA Fields Virology. 5th ed Philadelphia Lippincott, Williams & Wilkins 2847 2888
4. MesriEACesarmanEBoshoffC 2010 Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10 707 719
5. MoorePS 2007 KSHV manipulation of the cell cycle and apoptosis. ArvinACampadelli-FiumeGMocarskiESMoorePSRoizmanB Human herpesviruses Cambridge Cambridge University Press 2011/02/25 ed.
6. AmbrosV 2004 The functions of animal microRNAs. Nature 431 350 355
7. BartelDP 2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 281 297
8. KimVN 2005 MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6 376 385
9. DuTZamorePD 2005 microPrimer: the biogenesis and function of microRNA. Development 132 4645 4652
10. OkamuraKChungWJLaiEC 2008 The long and short of inverted repeat genes in animals: microRNAs, mirtrons and hairpin RNAs. Cell Cycle 7 2840 2845
11. MeisterGTuschlT 2004 Mechanisms of gene silencing by double-stranded RNA. Nature 431 343 349
12. EulalioAHuntzingerEIzaurraldeE 2008 Getting to the root of miRNA-mediated gene silencing. Cell 132 9 14
13. PillaiRSBhattacharyyaSNFilipowiczW 2007 Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17 118 126
14. LimLPLauNCGarrett-EngelePGrimsonASchelterJM 2005 Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 769 773
15. BartelDP 2009 MicroRNAs: target recognition and regulatory functions. Cell 136 215 233
16. OromUANielsenFCLundAH 2008 MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30 460 471
17. Stern-GinossarNElefantNZimmermannAWolfDGSalehN 2007 Host immune system gene targeting by a viral miRNA. Science 317 376 381
18. TayYZhangJThomsonAMLimBRigoutsosI 2008 MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455 1124 1128
19. SkalskyRLCullenBR 2010 Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64 123 141
20. PfefferSZavolanMGrasserFAChienMRussoJJ 2004 Identification of virus-encoded microRNAs. Science 304 734 736
21. PfefferS 2008 Viral miRNAs: tiny but mighty helpers for large and small DNA viruses. Future Virol 3 291 298
22. CaiXLuSZhangZGonzalezCMDamaniaB 2005 Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102 5570 5575
23. PfefferSSewerALagos-QuintanaMSheridanRSanderC 2005 Identification of microRNAs of the herpesvirus family. Nat Methods 2 269 276
24. SamolsMAHuJSkalskyRLRenneR 2005 Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79 9301 9305
25. GrundhoffASullivanCSGanemD 2006 A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12 733 750
26. GottweinEMukherjeeNSachseCFrenzelCMajorosWH 2007 A viral microRNA functions as an orthologue of cellular miR-155. Nature 450 1096 1099
27. SkalskyRLSamolsMAPlaisanceKBBossIWRivaA 2007 Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81 12836 12845
28. HengartnerMO 2000 The biochemistry of apoptosis. Nature 407 770 776
29. KedesDHGanemD 1997 Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 99 2082 2086
30. ArvanitakisLMesriEANadorRGSaidJWAschAS 1996 Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88 2648 2654
31. Segal-BendirdjianEJacquemin-SablonA 1995 Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process. Exp Cell Res 218 201 212
32. KoopmanGReutelingspergerCPKuijtenGAKeehnenRMPalsST 1994 Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84 1415 1420
33. GabayCBen-BassatHSchlesingerMLaskovR 1999 Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin's lymphoma cell lines. Eur J Haematol 63 180 191
34. Ben-BassatHGoldblumNMitraniSGoldblumTYoffeyJM 1977 Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19 27 33
35. DölkenLMaltererGErhardFKotheSFriedelCC 2010 Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7 324 334
36. SunYOrreniusSPervaizSFadeelB 2005 Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance. Blood 105 4070 4077
37. EdgellCJMcDonaldCCGrahamJB 1983 Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 80 3734 3737
38. LinYTKincaidRPArasappanDDowdSEHunicke-SmithSP 2010 Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs. RNA 16 1540 1558
39. SamolsMASkalskyRLMaldonadoAMRivaALopezMC 2007 Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3 e65
40. VieiraJO'HearnPM 2004 Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325 225 240
41. MeisterGLandthalerMDorsettYTuschlT 2004 Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10 544 550
42. ObadSdos SantosCOPetriAHeidenbladMBroomO 2011 Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 43 371 378
43. WangHWTrotterMWLagosDBourbouliaDHendersonS 2004 Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36 687 693
44. ZiegelbauerJMSullivanCSGanemD 2009 Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet 41 130 134
45. LeiXBaiZYeFXieJKimCG 2010 Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12 193 199
46. GottweinECullenBR 2010 A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol 84 5229 5237
47. AbendJRUldrickTZiegelbauerJM 2010 Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol 84 12139 12151
48. Henry-MowattJDiveCMartinouJCJamesD 2004 Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 23 2850 2860
49. RiedlSJSalvesenGS 2007 The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8 405 413
50. AshkenaziA 2002 Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2 420 430
51. RowinskyEK 2005 Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol 23 9394 9407
52. DebatinKMKrammerPH 2004 Death receptors in chemotherapy and cancer. Oncogene 23 2950 2966
53. BoldinMPVarfolomeevEEPancerZMettILCamonisJH 1995 A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270 7795 7798
54. ChenMWangJ 2002 Initiator caspases in apoptosis signaling pathways. Apoptosis 7 313 319
55. WalshJGCullenSPSheridanCLuthiAUGernerC 2008 Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci U S A 105 12815 12819
56. ModestiMBudzowskaMBaldeyronCDemmersJAGhirlandoR 2007 RAD51AP1 is a structure-specific DNA binding protein that stimulates joint molecule formation during RAD51-mediated homologous recombination. Mol Cell 28 468 481
57. KoopalSFuruhjelmJHJarviluomaAJaamaaSPyakurelP 2007 Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog 3 1348 1360
58. WangLDamaniaB 2008 Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res 68 4640 4648
59. Ramos da SilvaSBacchiMMBacchiCEElgui de OliveiraD 2007 Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions. Am J Clin Pathol 128 794 802
60. ZhouFCZhangYJDengJHWangXPPanHY 2002 Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 76 6185 6196
61. DiekerJCisternaBMonneauxFDecossasMvan der VlagJ 2008 Apoptosis-linked changes in the phosphorylation status and subcellular localization of the spliceosomal autoantigen U1-70K. Cell Death Differ 15 793 804
62. DölkenLPerotJCognatVAliouaAJohnM 2007 Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol 81 13771 13782
63. PfefferS 2007 Identification of Virally Encoded MicroRNAs. Methods Enzymol 427 51 63
64. ShiRChiangVL 2005 Facile means for quantifying microRNAs expression by real-time PCR. BioTechniques 39 519 525
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 12
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Controlling Viral Immuno-Inflammatory Lesions by Modulating Aryl Hydrocarbon Receptor Signaling
- Fungal Virulence and Development Is Regulated by Alternative Pre-mRNA 3′End Processing in
- Epstein-Barr Virus Nuclear Antigen 3C Stabilizes Gemin3 to Block p53-mediated Apoptosis
- Engineered Immunity to Infection